884 related articles for article (PubMed ID: 34980884)
1. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.
Liu J; Xiao Q; Xiao J; Niu C; Li Y; Zhang X; Zhou Z; Shu G; Yin G
Signal Transduct Target Ther; 2022 Jan; 7(1):3. PubMed ID: 34980884
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signalling in adrenal physiology and tumour development.
Berthon A; Martinez A; Bertherat J; Val P
Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signaling in cancers and targeted therapies.
Yu F; Yu C; Li F; Zuo Y; Wang Y; Yao L; Wu C; Wang C; Ye L
Signal Transduct Target Ther; 2021 Aug; 6(1):307. PubMed ID: 34456337
[TBL] [Abstract][Full Text] [Related]
4. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
5. Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway.
Sun X; He Y; Huang C; Ma TT; Li J
Cell Signal; 2013 Dec; 25(12):2805-11. PubMed ID: 24041653
[TBL] [Abstract][Full Text] [Related]
6. Genomic insights into WNT/β-catenin signaling.
Rosenbluh J; Wang X; Hahn WC
Trends Pharmacol Sci; 2014 Feb; 35(2):103-9. PubMed ID: 24365576
[TBL] [Abstract][Full Text] [Related]
7. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities.
Huang P; Yan R; Zhang X; Wang L; Ke X; Qu Y
Pharmacol Ther; 2019 Apr; 196():79-90. PubMed ID: 30468742
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.
Jung YS; Park JI
Exp Mol Med; 2020 Feb; 52(2):183-191. PubMed ID: 32037398
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signalling: from plasma membrane to nucleus.
Kim W; Kim M; Jho EH
Biochem J; 2013 Feb; 450(1):9-21. PubMed ID: 23343194
[TBL] [Abstract][Full Text] [Related]
10. How do they do Wnt they do?: regulation of transcription by the Wnt/β-catenin pathway.
Archbold HC; Yang YX; Chen L; Cadigan KM
Acta Physiol (Oxf); 2012 Jan; 204(1):74-109. PubMed ID: 21624092
[TBL] [Abstract][Full Text] [Related]
11. The way Wnt works: components and mechanism.
Saito-Diaz K; Chen TW; Wang X; Thorne CA; Wallace HA; Page-McCaw A; Lee E
Growth Factors; 2013 Feb; 31(1):1-31. PubMed ID: 23256519
[TBL] [Abstract][Full Text] [Related]
12. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA roles in beta-catenin pathway.
Huang K; Zhang JX; Han L; You YP; Jiang T; Pu PY; Kang CS
Mol Cancer; 2010 Sep; 9():252. PubMed ID: 20858269
[TBL] [Abstract][Full Text] [Related]
14. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease.
Aguilera O; Muñoz A; Esteller M; Fraga MF
Endocr Metab Immune Disord Drug Targets; 2007 Mar; 7(1):13-21. PubMed ID: 17346200
[TBL] [Abstract][Full Text] [Related]
16. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.
Bastakoty D; Young PP
FASEB J; 2016 Oct; 30(10):3271-3284. PubMed ID: 27335371
[TBL] [Abstract][Full Text] [Related]
18. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
de la Roche M; Worm J; Bienz M
BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
